Peter Moyle
@moylelab.bsky.social
Pharmacy lecturer, the University of Queensland. protein expression, peptide synthesis, subunit vaccines, gene therapy, delivery systems, PTMs. Views are my own
Reposted by Peter Moyle
🚨 Breakthrough Alert! 🚨
Bioresorbable Microbots are revolutionizing cancer treatment! These tiny bots deliver drugs directly to tumors, dissolve safely, and reduce side effects. 🌟💊
Learn more about this game-changing tech: scienceagenda.net/news/bioresorbable-microbots-transforming-tumor-treatment/
Bioresorbable Microbots are revolutionizing cancer treatment! These tiny bots deliver drugs directly to tumors, dissolve safely, and reduce side effects. 🌟💊
Learn more about this game-changing tech: scienceagenda.net/news/bioresorbable-microbots-transforming-tumor-treatment/
Bioresorbable Microbots: Transforming Tumor Treatment » Science Agenda
Bioresorbable Microbots target tumors with precision, dissolve safely, and revolutionize cancer treatment.
scienceagenda.net
December 19, 2024 at 12:24 AM
🚨 Breakthrough Alert! 🚨
Bioresorbable Microbots are revolutionizing cancer treatment! These tiny bots deliver drugs directly to tumors, dissolve safely, and reduce side effects. 🌟💊
Learn more about this game-changing tech: scienceagenda.net/news/bioresorbable-microbots-transforming-tumor-treatment/
Bioresorbable Microbots are revolutionizing cancer treatment! These tiny bots deliver drugs directly to tumors, dissolve safely, and reduce side effects. 🌟💊
Learn more about this game-changing tech: scienceagenda.net/news/bioresorbable-microbots-transforming-tumor-treatment/
Reposted by Peter Moyle
Super excited to finally share PANCS-Binders: our group's decade-long quest to accelerate protein binder discovery.
TLDR: PANCS-binders is fast (2 days), cheap (pennies), has extremely high fidelity (low false positive and negatives), and high-throughput.
1/n
TLDR: PANCS-binders is fast (2 days), cheap (pennies), has extremely high fidelity (low false positive and negatives), and high-throughput.
1/n
While everyone esle has been concentrating on generative binder design, this group has demonstrated screening libraries in vivo! www.biorxiv.org/content/10.1...
#biosky
#biosky
High-throughput protein binder discovery by rapid in vivo selection
Proteins that selectively bind to a target of interest are foundational components of research pipelines, diagnostics, and therapeutics. Current immunization-based, display-based, and computational ap...
www.biorxiv.org
January 7, 2025 at 8:50 PM
Super excited to finally share PANCS-Binders: our group's decade-long quest to accelerate protein binder discovery.
TLDR: PANCS-binders is fast (2 days), cheap (pennies), has extremely high fidelity (low false positive and negatives), and high-throughput.
1/n
TLDR: PANCS-binders is fast (2 days), cheap (pennies), has extremely high fidelity (low false positive and negatives), and high-throughput.
1/n
Reposted by Peter Moyle
The scientist who is responsible for driving GLP-1 drugs for the treatment of obesity and testing them for prevention of Alzheimer's disease—Lotte Bjerre Knudsen— tells her story in a remarkable conversation. Full transcript, or video, all free, no ads.
erictopol.substack.com/p/lotte-bjer...
erictopol.substack.com/p/lotte-bjer...
Lotte Bjerre Knudsen: The Scientist Who Drove GLP-1 Drugs For Obesity and Alzheimer's
Facts, data, and analytics about biomedical matters.
erictopol.substack.com
January 4, 2025 at 6:30 PM
The scientist who is responsible for driving GLP-1 drugs for the treatment of obesity and testing them for prevention of Alzheimer's disease—Lotte Bjerre Knudsen— tells her story in a remarkable conversation. Full transcript, or video, all free, no ads.
erictopol.substack.com/p/lotte-bjer...
erictopol.substack.com/p/lotte-bjer...